Literature DB >> 8550090

Analysis of variable region genes encoding anti-Sm and anti-cardiolipin antibodies from a systemic lupus erythematosus patient.

C Demaison1, C T Ravirajan, D A Isenberg, M Zouali.   

Abstract

We have analysed the heavy and light chain variable region genes of two monoclonal antibodies, specific for the Sm antigen (RSP1; IgG kappa) and for cardiolipin (RSP4; IgM lambda), derived from a patient with active systemic lupus erythematosus (SLE). We have established that the variable region genes of the RSP1 autoantibody are somatic mutants of two germ line genes from the VH4 and V kappa 1 gene families. RSP4 antibody uses gene segments closely related to a VH3 gene member and to a V lambda 1 gene. The presence and distribution of the somatic mutations on both monoclonal autoantibodies are compatible with an antigen-driven immune process. These data suggest that in SLE a common antigenic stimulus may govern the autoantibody response against a wide spectrum of unrelated antigens, including native DNA, cardiolipin or Sm antigens, and provide further evidence that disease-associated autoantibodies are generated through antigen-selected somatic mutations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8550090      PMCID: PMC1383956     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  38 in total

Review 1.  The origin, sequence, structure, and consequences of developing anti-DNA antibodies. A human perspective.

Authors:  D A Isenberg; M R Ehrenstein; C Longhurst; J K Kalsi
Journal:  Arthritis Rheum       Date:  1994-02

2.  Endonucleolytic activity that cleaves immunoglobulin recombination sequences.

Authors:  T J Hope; R J Aguilera; M E Minie; H Sakano
Journal:  Science       Date:  1986-03-07       Impact factor: 47.728

3.  Isotype progression and clonality of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice.

Authors:  R A Eisenberg; S Y Craven; P L Cohen
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

Review 4.  Mutation drift and repertoire shift in the maturation of the immune response.

Authors:  C Berek; C Milstein
Journal:  Immunol Rev       Date:  1987-04       Impact factor: 12.988

5.  Canonical structures for the hypervariable regions of immunoglobulins.

Authors:  C Chothia; A M Lesk
Journal:  J Mol Biol       Date:  1987-08-20       Impact factor: 5.469

Review 6.  Evolutionary and somatic selection of the antibody repertoire in the mouse.

Authors:  K Rajewsky; I Förster; A Cumano
Journal:  Science       Date:  1987-11-20       Impact factor: 47.728

7.  Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells.

Authors:  S V Desiderio; G D Yancopoulos; M Paskind; E Thomas; M A Boss; N Landau; F W Alt; D Baltimore
Journal:  Nature       Date:  1984 Oct 25-31       Impact factor: 49.962

8.  Early restriction of the human antibody repertoire.

Authors:  H W Schroeder; J L Hillson; R M Perlmutter
Journal:  Science       Date:  1987-11-06       Impact factor: 47.728

9.  Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice.

Authors:  R A Eisenberg; S Y Craven; R W Warren; P L Cohen
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

10.  Inter- and intraclonal diversity in the antibody response to influenza hemagglutinin.

Authors:  S H Clarke; K Huppi; D Ruezinsky; L Staudt; W Gerhard; M Weigert
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307

View more
  2 in total

1.  Demographic, autoimmune, and clinical profiles of patients with systemic lupus erythematosus in Oman.

Authors:  M H Al-Maini; E M El-Ageb; S S Al-Wahaibi; Y Al-Farsi; E R Richens
Journal:  Rheumatol Int       Date:  2003-04-02       Impact factor: 2.631

2.  Association of HLA-DM polymorphism with the production of antiphospholipid antibodies.

Authors:  M L Sanchez; K Katsumata; T Atsumi; F I Romero; M L Bertolaccini; A Funke; O Amengual; E Kondeatis; R W Vaughan; A Cox; G R V Hughes; M A Khamashta
Journal:  Ann Rheum Dis       Date:  2004-12       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.